ffectiveness of Physical Counterpressure aneuvers in Preventing Vasovagal Syncope

OBJECTIVES In this study, we assessed the effectiveness of physical counterpressure maneuvers (PCM) in daily life. BACKGROUND There is presently no evidence-based therapy for vasovagal syncope. Current treatment consists of explanation and life-style advice. Physical counterpressure maneuvers have been shown to raise blood pressure and to control or abort vasovagal episodes in laboratory conditions. METHODS We performed a multicenter, prospective, randomized clinical trial, which included 223 patients age 38.6 ( 15.4) years with recurrent vasovagal syncope and recognizable prodromal symptoms. One hundred and seventeen patients were randomized to standardized conventional therapy alone, and 106 patients received conventional therapy plus training in PCM. RESULTS The median yearly syncope burden during follow-up was significantly lower in the group trained in PCM than in the control group (p 0.004). During a mean follow-up period of 14 months, overall 50.9% of the patients with conventional treatment and 31.6% of the patients trained in PCM experienced a syncopal recurrence (p 0.005). Actuarial recurrencefree survival was better in the treatment group (log-rank p 0.018), resulting in a relative risk reduction of 39% (95% confidence interval, 11% to 53%). No adverse events were reported. CONCLUSIONS Physical counterpressure maneuvers are a risk-free, effective, and low-cost treatment method in patients with vasovagal syncope and recognizable prodromal symptoms, and should be advised as first-line treatment in patients presenting with vasovagal syncope with prodromal symptoms. (The PC-Trial; http://www.controlled-trials.com/isrctn/trial/45146526/0/ 45146526.html; ISRCTN45146526) (J Am Coll Cardiol 2006;48:1652–7) © 2006 by the ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.06.059